(2,2-Difluorotetrahydro-1H-pyrrolizin-7a(5H)-yl)methanol
97%
- Product Code: 36282
CAS:
1788873-48-2
| Molecular Weight: | 177.19 g./mol | Molecular Formula: | C₈H₁₃F₂NO |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD30802952 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | room temperature |
Product Description:
(2,2-Difluorotetrahydro-1H-pyrrolizin-7a(5H)-yl)methanol is primarily used in the pharmaceutical industry as a key intermediate in the synthesis of various biologically active compounds. Its unique structure, featuring difluorinated pyrrolizine, makes it valuable for developing drugs targeting specific enzymes or receptors. This compound is particularly relevant in the design of antiviral and anticancer agents, where its fluorinated moiety enhances metabolic stability and bioavailability. Additionally, it serves as a building block in medicinal chemistry for creating novel therapeutic molecules with improved efficacy and reduced side effects. Its applications extend to research settings, where it is utilized in the study of structure-activity relationships to optimize drug candidates.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.050 | 10-20 days | £177.50 |
+
-
|
(2,2-Difluorotetrahydro-1H-pyrrolizin-7a(5H)-yl)methanol
(2,2-Difluorotetrahydro-1H-pyrrolizin-7a(5H)-yl)methanol is primarily used in the pharmaceutical industry as a key intermediate in the synthesis of various biologically active compounds. Its unique structure, featuring difluorinated pyrrolizine, makes it valuable for developing drugs targeting specific enzymes or receptors. This compound is particularly relevant in the design of antiviral and anticancer agents, where its fluorinated moiety enhances metabolic stability and bioavailability. Additionally, it serves as a building block in medicinal chemistry for creating novel therapeutic molecules with improved efficacy and reduced side effects. Its applications extend to research settings, where it is utilized in the study of structure-activity relationships to optimize drug candidates.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
£0.00
£0.00
Total :